Sangamo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.07

+0.02 (+31.40%)

As of Jul 4, 10:43 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +26,989.5% upside

Low Target $11.90

Average Target $20.29

High Target $29.33

Current Price $0.07

Current
$0.07

Target
$20.29

$11.90 $20.29 avg $29.33

Scenario Analysis

Bear Case

$11.90

15,787.9%

Low target

Base Case

$20.29

+26,989.5%

Avg target

Bull Case

$29.33

+39,058.9%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$0.77

-90.2% from high

52-Week Low

$0.03

+149.7% from low

Target vs 52W High

$20.29

+2,548.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%